Herm Cukier, Senior Vice President for Eye Care at Allergan, and Mark Baum, CEO of Imprimis, speak with Mark Kontos, MD, regarding the future of the pharmaceutical business. Mr. Cukier shares insight into Allergan’s position on issues such as drug pricing and innovation in eye care. Mr. Baum explains the Imprimis business model of providing access and affordability for all patients. The two industry leaders also discuss the growth trends of their respective businesses.
Allergan • Imprimis Pharmaceuticals